Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist-Reference-Cited by-同舟云学术

Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist

Published:2005-03 Issue:3 Volume:45 Page:295-300
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Liles W. Conrad,Rodger Elin,Broxmeyer Hal E.,Dehner Christine,Badel Karin,Calandra Gary,Christensen Jeff,Wood Brent,Price Thomas H.,Dale David C.

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2005.04222.x/fullpdf

Reference38 articles.

1. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer.

2. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?

3. Current understanding of stem cell mobilization

4. The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of apheresis outcomes in a cohort of Chilean patients treated with autologous stem cell transplantation: A single center real-world experience;Transfusion and Apheresis Science;2024-10

2. Impact of plerixafor use in the mobilization of blood grafts for autologous hematopoietic cell transplantation;Transfusion;2024-02-26

3. Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation;Frontiers in Oncology;2023-08-28

4. Past, Present, and a Glance into the Future of Multiple Myeloma Treatment;Pharmaceuticals;2023-03-08

5. Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders;Frontiers in Genome Editing;2023-01-09